Hubbry Logo
EndocrinologyEndocrinologyMain
Open search
Endocrinology
Community hub
Endocrinology
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Endocrinology
Endocrinology
Endocrinology
View on Wikipedia
from Wikipedia
Endocrinology
Illustration depicting the primary endocrine organs of a female
SystemEndocrine
Significant diseasesDiabetes, Thyroid disease, Androgen excess
Significant testsThyroid function tests, Blood sugar levels
SpecialistEndocrinologist
GlossaryGlossary of medicine

Endocrinology (from endocrine + -ology) is a branch of biology and medicine dealing with the endocrine system, its diseases, and its specific secretions known as hormones. It is also concerned with the integration of developmental events proliferation, growth, and differentiation, and the psychological or behavioral activities of metabolism, growth and development, tissue function, sleep, digestion, respiration, excretion, mood, stress, lactation, movement, reproduction, and sensory perception caused by hormones. Specializations include behavioral endocrinology and comparative endocrinology.[1]

The endocrine system consists of several glands, all in different parts of the body, that secrete hormones directly into the blood rather than into a duct system. Therefore, endocrine glands are regarded as ductless glands. Hormones have many different functions and modes of action; one hormone may have several effects on different target organs, and, conversely, one target organ may be affected by more than one hormone.

The endocrine system

[edit]
Main article: Endocrine system

Endocrinology is the study of the endocrine system in the human body.[2] This is a system of glands which secrete hormones. Hormones are chemicals that affect the actions of different organ systems in the body. Examples include thyroid hormone, growth hormone, and insulin. The endocrine system involves a number of feedback mechanisms, so that often one hormone (such as thyroid stimulating hormone) will control the action or release of another secondary hormone (such as thyroid hormone). If there is too much of the secondary hormone, it may provide negative feedback to the primary hormone, maintaining homeostasis.[3][4][5]

In the original 1902 definition by Bayliss and Starling (see below), they specified that, to be classified as a hormone, a chemical must be produced by an organ, be released (in small amounts) into the blood, and be transported by the blood to a distant organ to exert its specific function. This definition holds for most "classical" hormones, but there are also paracrine mechanisms (chemical communication between cells within a tissue or organ), autocrine signals (a chemical that acts on the same cell), and intracrine signals (a chemical that acts within the same cell).[6] A neuroendocrine signal is a "classical" hormone that is released into the blood by a neurosecretory neuron (see article on neuroendocrinology).[citation needed]

Hormones

[edit]

Griffin and Ojeda identify three different classes of hormones based on their chemical composition:[7]

Amines

[edit]
Norepinephrine
Triiodothyronine
Examples of amine hormones

Amines, such as norepinephrine, epinephrine, and dopamine (catecholamines), are derived from single amino acids, in this case tyrosine. Thyroid hormones such as 3,5,3'-triiodothyronine (T3) and 3,5,3',5'-tetraiodothyronine (thyroxine, T4) make up a subset of this class because they derive from the combination of two iodinated tyrosine amino acid residues.[8]

Peptide and protein

[edit]

Peptide hormones and protein hormones consist of three (in the case of thyrotropin-releasing hormone) to more than 200 (in the case of follicle-stimulating hormone) amino acid residues and can have a molecular mass as large as 31,000 grams per mole. All hormones secreted by the pituitary gland are peptide hormones, as are leptin from adipocytes, ghrelin from the stomach, and insulin from the pancreas.[citation needed]

Steroid

[edit]
Cortisol
Vitamin D3
Examples of steroid hormones

Steroid hormones are converted from their parent compound, cholesterol. Mammalian steroid hormones can be grouped into five groups by the receptors to which they bind: glucocorticoids, mineralocorticoids, androgens, estrogens, and progestogens. Some forms of vitamin D, such as calcitriol, are steroid-like and bind to homologous receptors, but lack the characteristic fused ring structure of true steroids.

As a profession

[edit]
Endocrinologist
Occupation
NamesDoctor, Medical specialist
Occupation type
Specialty
Activity sectors
Medicine
Description
Education required
Fields of
employment
Hospitals, Clinics

Although every organ system secretes and responds to hormones (including the brain, lungs, heart, intestine, skin, and the kidneys), the clinical specialty of endocrinology focuses primarily on the endocrine organs, meaning the organs whose primary function is hormone secretion. These organs include the pituitary, thyroid, adrenals, ovaries, testes, and pancreas.

An endocrinologist is a physician who specializes in treating disorders of the endocrine system, such as diabetes, hyperthyroidism, and many others (see list of diseases).

Work

[edit]

The medical specialty of endocrinology involves the diagnostic evaluation of a wide variety of symptoms and variations and the long-term management of disorders of deficiency or excess of one or more hormones.[9]

The diagnosis and treatment of endocrine diseases are guided by laboratory tests to a greater extent than for most specialties. Many diseases are investigated through excitation/stimulation or inhibition/suppression testing. This might involve injection with a stimulating agent to test the function of an endocrine organ. Blood is then sampled to assess the changes of the relevant hormones or metabolites. An endocrinologist needs extensive knowledge of clinical chemistry and biochemistry to understand the uses and limitations of the investigations.

A second important aspect of the practice of endocrinology is distinguishing human variation from disease. Atypical patterns of physical development and abnormal test results must be assessed as indicative of disease or not. Diagnostic imaging of endocrine organs may reveal incidental findings called incidentalomas, which may or may not represent disease.[10]

Endocrinology involves caring for the person as well as the disease. Most endocrine disorders are chronic diseases that need lifelong care. Some of the most common endocrine diseases include diabetes mellitus, hypothyroidism and the metabolic syndrome. Care of diabetes, obesity and other chronic diseases necessitates understanding the patient at the personal and social level as well as the molecular, and the physician–patient relationship can be an important therapeutic process.

Apart from treating patients, many endocrinologists are involved in clinical science and medical research, teaching, and hospital management.

Training

[edit]

Endocrinologists are specialists of internal medicine or pediatrics. Reproductive endocrinologists deal primarily with problems of fertility and menstrual function—often training first in obstetrics. Most qualify as an internist, pediatrician, or gynecologist for a few years before specializing, depending on the local training system. In the U.S. and Canada, training for board certification in internal medicine, pediatrics, or gynecology after medical school is called residency. Further formal training to subspecialize in adult, pediatric, or reproductive endocrinology is called a fellowship. Typical training for a North American endocrinologist involves 4 years of college, 4 years of medical school, 3 years of residency, and 2 years of fellowship. In the US, adult endocrinologists are board certified by the American Board of Internal Medicine (ABIM) or the American Osteopathic Board of Internal Medicine (AOBIM) in Endocrinology, Diabetes and Metabolism.[citation needed]

Diseases treated by endocrinologists

[edit]
  • Diabetes mellitus: This is a chronic condition that affects how your body regulates blood sugar. There are two main types: type 1 diabetes, which is an autoimmune disease that occurs when the body attacks the cells that produce insulin, and type 2 diabetes, which is a condition in which the body either doesn't produce enough insulin or doesn't use it effectively.[11]
  • Thyroid disorders: These are conditions that affect the thyroid gland, a butterfly-shaped gland located in the front of your neck. The thyroid gland produces hormones that regulate your metabolism, heart rate, and body temperature. Common thyroid disorders include hyperthyroidism (overactive thyroid) and hypothyroidism (underactive thyroid).
  • Adrenal disorders: The adrenal glands are located on top of your kidneys. They produce hormones that help regulate blood pressure, blood sugar, and the body's response to stress. Common adrenal disorders include Cushing syndrome (excess cortisol production) and Addison's disease (adrenal insufficiency).
  • Pituitary disorders: The pituitary gland is a pea-sized gland located at the base of the brain. It produces hormones that control many other hormone-producing glands in the body. Common pituitary disorders include acromegaly (excess growth hormone production) and Cushing's disease (excess ACTH production).
  • Metabolic disorders: These are conditions that affect how your body processes food into energy. Common metabolic disorders include obesity, high cholesterol, and gout.
  • Calcium and bone disorders: Endocrinologists also treat conditions that affect calcium levels in the blood, such as hyperparathyroidism (too much parathyroid hormone) and osteoporosis (weak bones).
  • Sexual and reproductive disorders: Endocrinologists can also help diagnose and treat hormonal problems that affect sexual development and function, such as polycystic ovary syndrome (PCOS) and erectile dysfunction.
  • Endocrine cancers: These are cancers that develop in the endocrine glands. Endocrinologists can help diagnose and treat these cancers.

Diseases and medicine

[edit]

Diseases

[edit]
See main article at Endocrine diseases

Endocrinology also involves the study of the diseases of the endocrine system. These diseases may relate to too little or too much secretion of a hormone, too little or too much action of a hormone, or problems with receiving the hormone.

Societies and Organizations

[edit]

Because endocrinology encompasses so many conditions and diseases, there are many organizations that provide education to patients and the public. The Hormone Foundation is the public education affiliate of The Endocrine Society and provides information on all endocrine-related conditions. Other educational organizations that focus on one or more endocrine-related conditions include the American Diabetes Association, Human Growth Foundation, American Menopause Foundation, Inc., and American Thyroid Association.[12][13]

In North America the principal professional organizations of endocrinologists include The Endocrine Society,[14] the American Association of Clinical Endocrinologists,[15] the American Diabetes Association,[16] the Lawson Wilkins Pediatric Endocrine Society,[17] and the American Thyroid Association.[18]

In Europe, the European Society of Endocrinology (ESE) and the European Society for Paediatric Endocrinology (ESPE) are the main organisations representing professionals in the fields of adult and paediatric endocrinology, respectively.

In the United Kingdom, the Society for Endocrinology[19] and the British Society for Paediatric Endocrinology and Diabetes[20] are the main professional organisations.

The European Society for Paediatric Endocrinology[21] is the largest international professional association dedicated solely to paediatric endocrinology. There are numerous similar associations around the world.

History

[edit]
Arnold Berthold is known as a pioneer in endocrinology.

The earliest study of endocrinology began in China.[22] The Chinese were isolating sex and pituitary hormones from human urine and using them for medicinal purposes by 200 BC.[22] They used many complex methods, such as sublimation of steroid hormones.[22] Another method specified by Chinese texts—the earliest dating to 1110—specified the use of saponin (from the beans of Gleditsia sinensis) to extract hormones, but gypsum (containing calcium sulfate) was also known to have been used.[22]

Although most of the relevant tissues and endocrine glands had been identified by early anatomists, a more humoral approach to understanding biological function and disease was favoured by the ancient Greek and Roman thinkers such as Aristotle, Hippocrates, Lucretius, Celsus, and Galen, according to Freeman et al.,[23] and these theories held sway until the advent of germ theory, physiology, and organ basis of pathology in the 19th century.

In 1849, Arnold Berthold noted that castrated cockerels did not develop combs and wattles or exhibit overtly male behaviour.[24] He found that replacement of testes back into the abdominal cavity of the same bird or another castrated bird resulted in normal behavioural and morphological development, and he concluded (erroneously) that the testes secreted a substance that "conditioned" the blood that, in turn, acted on the body of the cockerel. In fact, one of two other things could have been true: that the testes modified or activated a constituent of the blood or that the testes removed an inhibitory factor from the blood. It was not proven that the testes released a substance that engenders male characteristics until it was shown that the extract of testes could replace their function in castrated animals. Pure, crystalline testosterone was isolated in 1935.[25]

Graves' disease was named after Irish doctor Robert James Graves,[26] who described a case of goiter with exophthalmos in 1835. The German Karl Adolph von Basedow also independently reported the same constellation of symptoms in 1840, while earlier reports of the disease were also published by the Italians Giuseppe Flajani and Antonio Giuseppe Testa, in 1802 and 1810 respectively,[27] and by the English physician Caleb Hillier Parry (a friend of Edward Jenner) in the late 18th century.[28] Thomas Addison was first to describe Addison's disease in 1849.[29]

Thomas Addison

In 1902 William Bayliss and Ernest Starling performed an experiment in which they observed that acid instilled into the duodenum caused the pancreas to begin secretion, even after they had removed all nervous connections between the two.[30] The same response could be produced by injecting extract of jejunum mucosa into the jugular vein, showing that some factor in the mucosa was responsible. They named this substance "secretin" and coined the term hormone for chemicals that act in this way.

Joseph von Mering and Oskar Minkowski made the observation in 1889 that removing the pancreas surgically led to an increase in blood sugar, followed by a coma and eventual death—symptoms of diabetes mellitus. In 1922, Banting and Best realized that homogenizing the pancreas and injecting the derived extract reversed this condition.[31]

Neurohormones were first identified by Otto Loewi in 1921.[32] He incubated a frog's heart (innervated with its vagus nerve attached) in a saline bath, and left in the solution for some time. The solution was then used to bathe a non-innervated second heart. If the vagus nerve on the first heart was stimulated, negative inotropic (beat amplitude) and chronotropic (beat rate) activity were seen in both hearts. This did not occur in either heart if the vagus nerve was not stimulated. The vagus nerve was adding something to the saline solution. The effect could be blocked using atropine, a known inhibitor to heart vagal nerve stimulation. Clearly, something was being secreted by the vagus nerve and affecting the heart. The "vagusstuff" (as Loewi called it) causing the myotropic (muscle enhancing) effects was later identified to be acetylcholine and norepinephrine. Loewi won the Nobel Prize for his discovery.

Recent work in endocrinology focuses on the molecular mechanisms responsible for triggering the effects of hormones. The first example of such work being done was in 1962 by Earl Sutherland. Sutherland investigated whether hormones enter cells to evoke action, or stayed outside of cells. He studied norepinephrine, which acts on the liver to convert glycogen into glucose via the activation of the phosphorylase enzyme. He homogenized the liver into a membrane fraction and soluble fraction (phosphorylase is soluble), added norepinephrine to the membrane fraction, extracted its soluble products, and added them to the first soluble fraction. Phosphorylase activated, indicating that norepinephrine's target receptor was on the cell membrane, not located intracellularly. He later identified the compound as cyclic AMP (cAMP) and with his discovery created the concept of second-messenger-mediated pathways. He, like Loewi, won the Nobel Prize for his groundbreaking work in endocrinology.[33]

See also

[edit]

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Endocrinology

View on Grokipedia
from Grokipedia
Endocrinology is the branch of biology and medicine that studies the endocrine system, focusing on the production, functions, and disturbances of hormones, which are chemical messengers secreted by glands to regulate essential bodily processes such as , growth, , and . The endocrine system comprises specialized glands—including the pituitary, , adrenal glands, , and gonads—that release hormones directly into the bloodstream to communicate between different organs and tissues, influencing a wide array of physiological functions like , , mood, stress response, and development. Hormones, numbering over 50 distinct types, play a in maintaining balance within the body; for instance, insulin from the regulates sugar, while govern metabolic rate. Endocrinologists, medical specialists in this field, diagnose and treat disorders arising from hormonal imbalances through methods such as tests, , biopsies, medications, and sometimes , often managing chronic conditions over the long term. Common endocrine disorders include , thyroid diseases (e.g., or ), adrenal conditions like , pituitary tumors, obesity-related hormonal issues, , and certain cancers affecting endocrine glands. The field has evolved significantly since the late , with milestones such as the use of adrenal extracts to treat in 1896 and the purification of insulin in 1921, which laid the foundation for replacement therapies and modern treatments. Subspecialties like pediatric endocrinology, which addresses growth and issues in children, and molecular endocrinology, exploring actions at the cellular level, highlight the discipline's breadth and its contributions to understanding major challenges. Overall, endocrinology remains vital for advancing knowledge on -related diseases, improving patient outcomes through targeted interventions, and integrating , , and environmental factors into holistic care.

Endocrine System Fundamentals

Major Endocrine Glands

The endocrine system comprises several major glands and organs that produce and secrete hormones directly into the bloodstream to regulate various physiological processes, including growth, , , and stress response. These glands are distributed throughout the body and often work in interconnected networks to maintain . Key components include the , , thyroid gland, parathyroid glands, adrenal glands, , gonads, and , each with distinct anatomical locations and secretory functions. The , located in the lower central region of the within the , serves as a critical link between the nervous and endocrine systems. It synthesizes , such as (CRH) and (TRH), which are transported via the hypothalamic-hypophyseal portal system to regulate the . Structurally, the hypothalamus consists of neuronal clusters that produce these regulatory factors, enabling it to coordinate responses to environmental and internal stimuli like temperature, appetite, and . Closely associated with the is the , a small, pea-sized situated at the base of the in the of the , connected by the . This gland is divided into the , which secretes hormones like (ACTH), (TSH), (GH), and to stimulate target glands and tissues, and the , which stores and releases hormone (ADH) and oxytocin synthesized in the . The hypothalamic-pituitary axis represents a central interconnection, where hypothalamic hormones control pituitary secretions, which in turn regulate peripheral endocrine glands such as the and adrenals, forming a hierarchical coordination system for overall endocrine function. The gland, a butterfly-shaped organ located in the anterior neck below the and in front of the trachea, consists of two lobes connected by an isthmus and is composed of follicles lined with follicular cells that produce thyroxine (T4) and (T3). These hormones primarily regulate , energy production, and growth by influencing cellular oxygen consumption and protein synthesis. Embedded within the thyroid are parafollicular C cells, which secrete calcitonin to help maintain calcium . Positioned on the posterior surface of the thyroid are the four parathyroid glands, small pea-sized structures typically embedded in the thyroid's capsule. These glands secrete (PTH), which acts to elevate blood calcium levels by stimulating , enhancing renal calcium reabsorption, and promoting activation. Their structure features chief cells as the primary secretory units, with oxyphil cells of uncertain function. The adrenal glands, also known as suprarenal glands, are paired pyramid-shaped organs perched atop each in the . Each gland has an outer , divided into zones that produce glucocorticoids like to manage stress responses and , mineralocorticoids such as aldosterone for and , and small amounts of androgens; the inner , derived from tissue, secretes catecholamines including epinephrine and norepinephrine to mediate acute stress reactions. This zonal structure allows the adrenals to respond to both long-term regulatory signals from the pituitary and rapid neural inputs. The , an elongated organ situated in the behind the and between the and , functions both exocrine and endocrine. Its endocrine component, the s of Langerhans, comprises clusters of cells dispersed throughout the organ, including alpha cells that secrete to raise blood glucose levels and beta cells that produce insulin to lower it, thereby maintaining glucose essential for energy . Other islet cell types, such as delta cells secreting , contribute to fine-tuning these processes. The gonads, serving as both reproductive and endocrine organs, include the ovaries in females, located in the on either side of the , and the testes in males, housed in the . Ovaries secrete and progesterone to regulate reproductive cycles, secondary , and maintenance, while testes produce testosterone to support , muscle development, and male secondary sex traits. These glands' functions are modulated by pituitary gonadotropins via the hypothalamic-pituitary-gonadal axis, illustrating another key interconnection. Finally, the , a small pinecone-shaped structure embedded in the at the center of the near the third ventricle, primarily secretes to modulate circadian rhythms and sleep-wake cycles in response to light-dark cues. Composed mainly of pinealocytes and supporting glia, it receives neural input from the via the , linking it indirectly to the broader neuroendocrine network.

Hormone Regulation Mechanisms

Hormone regulation in the endocrine system relies on intricate control mechanisms that ensure precise levels to maintain . These mechanisms integrate feedback loops, rhythmic patterns, neural inputs, and hierarchical signaling to respond dynamically to physiological needs. Central to this is the hypothalamic-pituitary axis, where the orchestrates responses through releasing and inhibiting factors that modulate pituitary , ultimately influencing peripheral glands. Negative feedback loops predominate in endocrine regulation, where elevated hormone levels inhibit upstream signals to prevent overproduction. For instance, in the hypothalamic-pituitary-adrenal (HPA) axis, cortisol from the adrenal cortex binds to glucocorticoid receptors in the hypothalamus and pituitary, suppressing the release of corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH), respectively. This loop maintains cortisol within physiological ranges, with mineralocorticoid receptors providing additional fine-tuning for homeostasis. Positive feedback, though rarer, amplifies signals temporarily; in the HPA system, it can stabilize responses during acute stress by enhancing initial CRH-ACTH surges before negative feedback dominates. Many hormones exhibit , characterized by episodic bursts superimposed on a baseline, which is essential for effective receptor activation and preventing desensitization. (GnRH) from hypothalamic neurons pulses every 45-180 minutes, driving corresponding (LH) pulses from the pituitary to support reproductive function; disruptions in this rhythm can lead to hypogonadotropism. Similarly, ACTH occurs in ultradian pulses modulated by CRH, contributing to cortisol's daily profile. These patterns arise from synchronized neuronal firing and calcium-dependent in secretory cells. Circadian rhythms further impose 24-hour oscillations on hormone secretion, synchronized by the (SCN) in the to align with environmental cues like light-dark cycles. , secreted by the , peaks nocturnally (around 02:00-04:00) under darkness, driven by norepinephrine activation of arylalkylamine N-acetyltransferase; light exposure rapidly suppresses this via SCN-mediated inhibition. This rhythm integrates photoperiod information to regulate and seasonal breeding, with plasma levels reaching 60-70 pg/mL at night. also follows a circadian , with morning acrophase tied to ACTH pulses, underscoring the interplay between ultradian and circadian controls. Neural regulation modulates endocrine activity through the (ANS) and direct hypothalamic inputs, enabling rapid adjustments to stressors or metabolic changes. The , particularly the paraventricular nucleus (PVN), integrates sensory signals and projects to autonomic centers, activating sympathetic pathways to stimulate catecholamine release or parasympathetic inputs for glandular inhibition. For example, sympathetic innervation enhances pancreatic insulin secretion during , while hypothalamic CRH neurons in the PVN coordinate HPA activation alongside ANS responses like increased . This neural overlay allows the endocrine system to respond within seconds, complementing slower hormonal feedback. Hormonal hierarchies establish a tiered control structure, with primary signals from the directing secondary pituitary tropic hormones that govern tertiary peripheral outputs. Hypothalamic releasing hormones, such as CRH, GnRH, and (TRH), are secreted into the to stimulate cells, exemplifying primary control. Pituitary tropic hormones like ACTH, LH/FSH, and TSH then act on target glands (adrenals, gonads, ) as secondary regulators, with from end hormones closing the loop. This cascade, rooted in the as the apex, ensures coordinated multi-level regulation across the endocrine axes.

Hormone Classification and Function

Chemical Classes of Hormones

Hormones are classified into three primary chemical classes based on their molecular structure and biosynthetic pathways: amine-derived hormones, peptide and protein hormones, and steroid hormones. This categorization reflects differences in their synthesis, physicochemical properties, and physiological handling, which are critical for understanding endocrine function. Amine-derived hormones originate from amino acids, specifically tyrosine or tryptophan, and include several subclasses with distinct properties. Catecholamines, such as epinephrine and norepinephrine, are synthesized from tyrosine via sequential enzymatic hydroxylation and decarboxylation in the adrenal medulla and sympathetic neurons. These hormones are water-soluble and exhibit very short half-lives, typically around 1-2 minutes, allowing rapid signaling. Thyroid hormones, thyroxine (T4) and triiodothyronine (T3), are also derived from tyrosine but undergo iodination within the thyroid gland, resulting in lipid-soluble molecules with longer half-lives—T4 approximately 7 days and T3 about 1 day. Additionally, melatonin, derived from tryptophan in the pineal gland, is a lipid-soluble amine hormone involved in regulating sleep-wake cycles, with a half-life of about 45 minutes and circulating primarily bound to albumin. Peptide and protein hormones consist of chains of produced through transcription, ribosomal on the rough , and subsequent post-translational modifications such as cleavage and in the Golgi apparatus. These hormones are water-soluble and generally have half-lives ranging from minutes to hours, enabling precise regulation of physiological processes. Representative examples include insulin, a 51-amino-acid secreted by pancreatic beta cells, and , a 191-amino-acid protein produced by the . Steroid hormones are synthesized from as the precursor lipid, involving enzyme-mediated conversions primarily in the mitochondria and smooth of endocrine cells. Due to their lipophilic nature, these hormones readily diffuse across cell membranes and possess half-lives typically in the range of 30 minutes to several hours. Key examples are , produced by the , and (), synthesized in the ovaries. The chemical classes differ markedly in solubility, transport mechanisms, and persistence in circulation, as summarized below:
Chemical ClassSolubilityTransport in BloodTypical Half-LifeExamples
Amine-derivedWater-soluble (catecholamines); Lipid-soluble (, )Mostly unbound (catecholamines); Bound to (); Bound to ()Seconds to minutes (catecholamines); Days (); ~45 minutes ()Epinephrine, ,
Peptide/ProteinWater-solubleMostly unbound; some bound to carriersMinutes to hoursInsulin,
SteroidLipid-soluble>90% bound to plasma proteins (e.g., corticosteroid-binding globulin, )Minutes to hours, estrogen
These properties arise from the structural features of each class and influence their storage, release, and elimination.

Mechanisms of Hormone Action

Hormones exert their physiological effects by binding to specific receptors on or within target cells, initiating a cascade of intracellular events that lead to changes in cellular function. This interaction ensures precise regulation of processes such as , growth, and . The mechanisms vary depending on the hormone's chemical , with water-soluble hormones typically acting through cell surface receptors and lipid-soluble hormones through intracellular receptors. Cell surface receptors, predominantly G-protein-coupled receptors (GPCRs), mediate the actions of peptide hormones and many amines. For instance, glucagon binds to its GPCR on liver cells, activating heterotrimeric G-proteins that stimulate adenylyl cyclase to produce cyclic AMP (cAMP) as a second messenger. This pathway exemplifies rapid signaling, where cAMP activates protein kinase A, leading to phosphorylation of target proteins and quick metabolic responses. In contrast, nuclear receptors handle steroid and thyroid hormones; thyroid hormone (T3) diffuses across the cell membrane and binds to thyroid hormone receptors (TRs) in the cytoplasm or nucleus, forming a complex that regulates gene transcription by binding to thyroid hormone response elements (TREs) on DNA. Signal transduction pathways amplify the initial hormone signal and confer specificity. For GPCRs, second messengers like cAMP or (IP3) trigger downstream cascades, such as the (MAPK) pathway, enabling one hormone molecule to influence thousands of effector molecules. Steroid hormones, via nuclear receptors, induce slower but longer-lasting effects through altered , recruiting coactivators to enhance transcription of responsive genes. Cytokines and growth factors, including , utilize the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway; upon binding, receptor-associated JAKs phosphorylate STAT proteins, which dimerize and translocate to the nucleus to modulate transcription. Specificity arises from hormone-receptor binding affinities, often in the nanomolar range, ensuring selective activation in target tissues. Amplification in these pathways allows minimal concentrations to produce robust responses; for example, less than 5% can elicit a maximal effect due to enzymatic cascades where each step multiplies the signal. Downstream elements, like the JAK-STAT or MAPK pathways, further enhance this by integrating multiple inputs for fine-tuned cellular decisions. High-affinity binding, characterized by dissociation constants (Kd) typically below 10^{-9} M, prevents off-target effects and maintains physiological precision. Hormone resistance occurs when mutations impair receptor function, leading to reduced cellular responsiveness. In thyroid hormone resistance syndrome, heterozygous mutations in the thyroid hormone receptor β (TRβ) gene produce dominant-negative receptors that heterodimerize with wild-type receptors, inhibiting normal transcriptional activation. Similarly, results from loss-of-function mutations in the gene, disrupting binding or coactivator and causing phenotypic resistance despite normal hormone levels. These molecular defects highlight the critical role of receptor integrity in hormone signaling.

Clinical Practice in Endocrinology

Diagnostic Techniques

Diagnostic techniques in endocrinology encompass a range of , , and functional assessments designed to evaluate levels, glandular structure, and dynamic responses, enabling the identification of hypo- or in the endocrine system. These methods are essential for confirming suspected abnormalities, guiding differential diagnoses, and monitoring disease progression, often integrated based on clinical presentation. Laboratory tests form the cornerstone, providing quantitative measures of hormone concentrations, while imaging offers structural insights, and provocative tests reveal functional reserve. Genetic analyses complement these by uncovering underlying molecular defects in hereditary conditions. Laboratory tests primarily involve assays to measure circulating levels of endocrine products, with immunoassays such as enzyme-linked immunosorbent assay (ELISA) commonly used for peptides like insulin due to its high in detecting low concentrations. For hormones, liquid chromatography-tandem (LC-MS/MS) is preferred for its superior accuracy and ability to distinguish between structurally similar analytes, reducing interference seen in immunoassays. Dynamic tests, such as the oral (OGTT), assess metabolic responses by measuring glucose and insulin levels before and after a standardized glucose load, aiding in the of diabetes mellitus. These assays are standardized by organizations like the to ensure reproducibility across clinical settings. Imaging modalities provide non-invasive visualization of endocrine glands and related structures. Ultrasonography is the initial choice for evaluating thyroid nodules, offering real-time assessment of size, vascularity, and solidity to differentiate benign from malignant lesions. (MRI) excels in delineating pituitary tumors, providing high-resolution images of soft tissues without , crucial for identifying microadenomas. (DEXA) scans measure bone mineral density, essential in conditions like where excess leads to , quantifying risk via T-scores. Selection of imaging follows guidelines from bodies such as the American College of Radiology to optimize diagnostic yield. Stimulation and suppression tests probe the functional integrity of endocrine axes by challenging glands with exogenous agents. The evaluates adrenal function in suspected insufficiency by administering synthetic cosyntropin and measuring response; a peak below 15 μg/dL (depending on the ) indicates primary or secondary adrenal failure. The thyrotropin-releasing hormone (TRH) stimulation test assesses pituitary thyrotroph reserve, with and TSH levels monitored post-infusion to detect . These protocols are rigorously defined to minimize variability and ensure safety, often requiring inpatient monitoring for acute responses. Genetic and molecular diagnostics target inherited endocrine disorders through techniques like polymerase chain reaction (PCR) for detecting mutations in key genes. In congenital adrenal hyperplasia (CAH), PCR-based sequencing identifies CYP21A2 variants responsible for 21-hydroxylase deficiency, enabling prenatal diagnosis and carrier screening with high analytical sensitivity. Next-generation sequencing panels expand this to multiple endocrine genes, facilitating comprehensive evaluation in complex cases. These methods adhere to best practice guidelines from the European Molecular Genetics Quality Network for accurate variant interpretation.

Treatment Modalities

Treatment modalities in endocrinology primarily aim to restore hormonal balance, alleviate symptoms, and prevent complications from endocrine imbalances through targeted interventions. These approaches include to supplement deficient s, surgical removal of dysfunctional glands or tumors, pharmacological agents that modulate production or action, and emerging therapies leveraging advanced biotechnologies. Selection of therapy depends on the specific disorder, its severity, and factors, often following diagnostic confirmation to ensure appropriate application. Hormone replacement therapy (HRT) is a cornerstone for managing hypo-secretory conditions by providing exogenous hormones to mimic physiological levels. For , , a synthetic form of thyroxine (T4), is the standard treatment, administered orally at doses typically starting at 1.6 mcg/kg body weight daily, which normalizes (TSH) levels in over 90% of patients within 6-8 weeks. In , insulin analogs such as lispro or glargine are used for replacement, with basal-bolus regimens reducing hemoglobin A1c (HbA1c) by 0.5-1.5% compared to conventional therapy, as established in landmark trials like the Control and Complications . For , replacement at 15-25 mg/day in divided doses prevents and maintains normal rhythms. Surgical interventions are indicated for localized endocrine pathologies, such as tumors or hyperfunctioning glands, offering definitive cures in select cases. , the surgical removal of all or part of the gland, is a primary option for when medical therapy fails, achieving remission rates of 90-95% with lower recurrence than antithyroid drugs (2.1% vs. 58.5%), though it carries risks of (1-6%) and injury (1-2%). For , laparoscopic is the gold standard, recommended by guidelines for tumors up to 6 cm, with minimally invasive approaches reducing hospital stay to 1-2 days and complication rates below 10% compared to open . Partial may preserve function in bilateral cases to avoid lifelong steroid dependence. Pharmacological agents beyond replacement therapy target hormone excess or receptor activity to control overproduction. In primary hyperaldosteronism, spironolactone, a , is first-line medical therapy at 25-100 mg/day, normalizing and in 60-70% of patients unsuitable for surgery, as per updated guidelines. For acromegaly, somatostatin analogs like octreotide LAR (20-30 mg intramuscularly monthly) or lanreotide autogel (90-120 mg subcutaneously every 4 weeks) normalize (IGF-1) in 40-75% of patients by inhibiting secretion from pituitary adenomas. Emerging therapies are expanding options for refractory or rare endocrine disorders, particularly autoimmune and genetic conditions. Gene therapy shows promise for congenital disorders like steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia, where AAV-mediated delivery of the CYP21A2 gene has restored enzyme activity in preclinical models, potentially reducing steroid dependence. In 2024, crinecerfont was approved by the FDA for classic CAH, providing a novel cortisol synthesis modulator to manage androgen excess without lifelong glucocorticoids. Monoclonal antibodies targeting autoimmune pathways, such as teprotumumab (an anti-IGF-1R antibody administered intravenously at 10 mg/kg initially then 20 mg/kg every 3 weeks for 8 cycles), have revolutionized management of Graves' ophthalmopathy, improving proptosis by 2-3 mm and diplopia in 70-80% of patients, outperforming steroids in phase 3 trials. These biologics, including rituximab for B-cell depletion in Graves' disease, achieve remission rates of 48% at 24 months in young patients, higher than conventional antithyroid drugs alone.

Endocrine Disorders

Hypo- and Hypersecretory Conditions

Hypo- and hypersecretory conditions encompass a spectrum of endocrine disorders characterized by underproduction or overproduction of hormones from glands such as the adrenals, pituitary, and , resulting in disrupted and multisystem effects. These imbalances often stem from etiologies including tumors, autoimmune processes, and iatrogenic factors, leading to symptoms that reflect the specific hormone's role in , balance, and stress response. Early recognition is crucial, as untreated cases can progress to severe complications like crises or , though diagnostic confirmation and management align with established clinical protocols. Hyposecretory conditions arise from inadequate hormone secretion, impairing vital regulatory functions. , a form of primary , exemplifies this through deficient and aldosterone production by the , manifesting in chronic fatigue, muscle weakness, appetite loss, weight reduction, abdominal discomfort, , and salt cravings, alongside from compensatory ACTH elevation. In developed countries, autoimmune adrenalitis accounts for 80-90% of cases, with other causes including infections such as or , adrenal hemorrhage, metastases, and genetic disorders like . A life-threatening complication is , precipitated by stress or infection, featuring severe , , , vomiting, and shock, which demands immediate intervention to prevent mortality. Hypopituitarism represents another key hyposecretory disorder, involving partial or complete failure of the to secrete one or more tropic hormones, thereby causing secondary deficiencies in downstream endocrine organs. Symptoms vary by affected axis: (ACTH) deficiency leads to profound fatigue, , , and increased infection susceptibility; (TSH) shortfall induces with cold intolerance, weight gain, constipation, and dry skin; deficiencies result in , low , amenorrhea, or ; and lack contributes to reduced muscle mass and energy in adults or in children. Primary etiologies include pituitary adenomas (the most frequent, affecting up to 61% of cases), , surgical or radiation damage, inflammatory conditions like lymphocytic , and infiltrative diseases such as . Complications encompass from ACTH deficiency and, in severe TSH-related , myxedema coma—a rare, emergent state marked by , , , altered consciousness, and multiorgan failure, often triggered by infection or sedatives, with high mortality if unrecognized. Hypersecretory conditions, conversely, involve excessive hormone output, accelerating physiological processes and causing catabolic states. arises from chronic excess, producing central obesity, a rounded ", dorsal ", purple striae, proximal , , , easy bruising, and impaired glucose tolerance, with women additionally experiencing and menstrual irregularities, and men facing reduced fertility. Exogenous causes predominate, stemming from prolonged high-dose therapy for conditions like or ; endogenous origins include pituitary adenomas (, responsible for about 70% of such cases), ectopic ACTH-secreting tumors (e.g., in the lungs or ), and primary adrenal adenomas or carcinomas. Long-term effects heighten risks of , , and fractures due to bone loss. Hyperthyroidism illustrates hypersecretion via overproduction, yielding unintended weight loss, , , , tremors, anxiety, diaphoresis, , and proximal , with goiter or eye protrusion in specific forms. , an autoimmune etiology driven by thyroid-stimulating immunoglobulins mimicking TSH, accounts for 60-80% of cases, while toxic thyroid nodules—either solitary adenomas or multinodular goiters—cause autonomous release in 10-20% of instances. A critical complication is , an acute, potentially fatal escalation in untreated or stressed patients, presenting with hyperpyrexia (up to 106°F), severe (>140 bpm), , gastrointestinal distress, and , carrying an 8-25% mortality rate despite supportive care. Across both hypo- and hypersecretory disorders, tumors like adenomas promote excess or suppression via mass effects or ectopic production, autoimmune mechanisms destroy or stimulate glands aberrantly, and iatrogenic factors such as withdrawal or overdose exacerbate imbalances.

Metabolic and Autoimmune Disorders

Metabolic disorders in endocrinology encompass conditions where hormonal dysregulation disrupts , glucose , and lipid balance, often leading to systemic complications. mellitus arises from destruction of pancreatic beta cells, resulting in absolute insulin deficiency and . This process involves the production of autoantibodies targeting islet cells, such as insulin autoantibodies (IAA), glutamic acid decarboxylase antibodies (GADA), insulinoma-associated antigen-2 antibodies (IA-2A), and zinc transporter 8 antibodies (ZnT8A), which serve as markers of ongoing beta-cell autoimmunity. The destruction is T-cell mediated, leading to insulitis and progressive loss of insulin-secreting capacity, typically manifesting in childhood or . In contrast, type 2 diabetes mellitus is characterized by peripheral coupled with progressive beta-cell dysfunction, where initial compensatory eventually fails, leading to relative insulin deficiency. primarily affects , liver, and , impairing and promoting hepatic , while beta-cell failure involves deposition, , and that exhaust secretory function over time. This dual contributes to chronic and increases cardiovascular risk. exacerbates these processes through leptin dysregulation; , an secreted by adipocytes, normally signals and energy expenditure via hypothalamic receptors, but in obesity, elevated leptin levels induce central leptin resistance, failing to suppress or enhance , thereby perpetuating adipose accumulation and metabolic inflammation. Autoimmune endocrine disorders involve immune-mediated attacks on glandular tissues, often resulting in organ-specific failure. , the most common cause of , features lymphocytic infiltration of the thyroid gland driven by autoantibodies against (anti-TPO), which disrupt hormone synthesis by targeting the enzyme essential for iodination of . Anti-TPO antibodies promote complement activation and , leading to follicular cell destruction and , with genetic factors like HLA-DR3 and environmental triggers such as iodine excess contributing to disease initiation. , as noted, shares this autoimmune etiology, with islet autoantibodies preceding clinical onset by years and facilitating early screening. Polycystic ovary syndrome (PCOS) represents a complex endocrine-metabolic disorder marked by ovarian dysfunction, , and , affecting reproductive-aged women. Elevated androgens, such as testosterone and , arise from cell hyperactivity in polycystic ovaries, disrupting and causing , while amplifies this through , which stimulates ovarian cytochrome P450c17 activity to boost production. This interplay fosters a vicious cycle, with androgens further impairing insulin signaling in peripheral tissues, leading to visceral adiposity and . Long-term sequelae of these disorders underscore their metabolic and immune impacts. In type 1 diabetes, uncontrolled hyperglycemia can precipitate diabetic ketoacidosis (DKA), a life-threatening state where insulin deficiency shifts metabolism to ketogenesis, producing acidic ketones that cause metabolic acidosis, dehydration, and electrolyte imbalances, often triggered by infection or omitted insulin doses. Similarly, primary hyperparathyroidism, involving parathyroid hormone (PTH) overproduction, drives osteoporosis by enhancing osteoclast activity and bone resorption to maintain serum calcium, preferentially affecting cortical bone and increasing fracture risk, independent of vitamin D status. These complications highlight the need for vigilant monitoring to mitigate endocrine-metabolic progression.

Historical Development

Early Discoveries and Milestones

The earliest recorded observations of endocrine-related conditions date back to ancient civilizations, where symptoms suggestive of hormonal imbalances were noted without understanding their physiological basis. In , around 1500 BCE, medical texts such as the described a condition characterized by excessive urination, now recognized as diabetes mellitus, attributing it to the passage of flesh through the body's heating apparatus. This marked one of the first documented recognitions of a disorder linked to pancreatic dysfunction, though treatments like herbal remedies and incantations reflected the era's limited scientific framework. Building on these observations, the Roman physician (129–c. 216 CE) developed the humoral theory in the 2nd century CE, positing that health depended on the balance of four bodily fluids—, , yellow , and black —secreted by organs to maintain equilibrium. 's ideas, which dominated Western medicine for over a millennium, laid conceptual groundwork for later endocrine concepts by emphasizing internal secretions and organ-specific roles in regulating bodily functions, influencing how imbalances were viewed as causes of . The brought experimental advances that shifted endocrinology toward empirical . In 1849, German physiologist Arnold Berthold conducted pioneering transplantation experiments on roosters, removing testes from capons (castrated roosters) and reimplanting them into the without vascular connections. These birds regained male secondary sexual characteristics, such as comb growth and aggressive behavior, demonstrating that the testes produced a circulating substance responsible for these traits, thus providing early evidence for internal secretions independent of neural control. Berthold's work, published in 1849, is widely regarded as the first endocrine experiment, bridging and . Key milestones in hormone isolation followed in the early 20th century, solidifying the field's foundations. In 1914, American biochemist Edward C. Kendall at the isolated thyroxine, the primary , in crystalline form from thyroid gland extracts, enabling its chemical characterization and therapeutic use for . This achievement, detailed in Kendall's 1915 publication, represented the first successful purification of a mammalian and advanced understanding of regulation. Seven years later, in 1921, Canadian researchers Frederick G. Banting and Charles H. Best extracted insulin from canine pancreases at the , successfully reducing blood glucose in diabetic dogs and paving the way for human treatment. Their method involved ligating pancreatic ducts to minimize digestive enzyme damage, yielding an active extract tested ; clinical trials began in 1922, transforming from a fatal condition. The formal establishment of endocrinology as a discipline occurred in 1905, when British physiologist Ernest H. Starling coined the term "" during his Croonian Lectures to describe chemical messengers like , produced by endocrine glands and transported via blood to target organs. This conceptualization distinguished hormonal from neural regulation, founding the field. Institutional recognition followed with the formation of the in 1916 by American physicians, including Frank R. Lillie and others, to promote research on internal secretions; it began publishing the journal Endocrinology in 1917, fostering global collaboration.

Modern Advances and Key Figures

In the mid-20th century, molecular endocrinology advanced significantly with the development of (RIA) by Rosalyn Yalow and Solomon Berson in the 1950s at the Veterans Administration Hospital. This technique used radioactive isotopes to measure minute hormone concentrations in blood, revolutionizing diagnostics for conditions like and disorders by enabling precise quantification previously impossible with bioassays. Yalow's contributions earned her the in Physiology or Medicine in 1977, shared with and for peptide hormone research, though Berson, who died in 1972, was not eligible; the prize recognized RIA's impact on understanding hormone regulation. The 1980s brought recombinant DNA technology to endocrinology, allowing production of human hormones in bacteria. synthesized recombinant human insulin in 1978, which the FDA approved in 1982 as Humulin—the first biotechnology-derived drug—providing a safer alternative to animal-sourced insulin and treating millions with . Similarly, recombinant human growth hormone (hGH), first produced by in 1979 with clinical trials beginning in 1981, was approved in 1985 as Protropin, addressing without risks from cadaver-derived sources linked to Creutzfeldt-Jakob disease. Recent milestones include the 1994 discovery of , a encoded by the ob in , by researchers led by Jeffrey M. Friedman at , building on Douglas Coleman's parabiotic studies; leptin's role in appetite suppression offered new insights into as a hormonal disorder rather than solely behavioral. In the 2000s, (GLP-1) receptor agonists emerged as transformative therapies for . , a synthetic exendin-4 analog from saliva, was FDA-approved in 2005 as Byetta, mimicking GLP-1 to enhance insulin secretion, slow gastric emptying, and promote weight loss; followed in 2010, further establishing this class's efficacy in glycemic control. Building on these, , another GLP-1 agonist, was approved by the FDA in 2017 for and in 2021 for chronic , significantly impacting treatment and metabolic health for millions as of 2025. Key figures in endocrinology include , who in 1905 coined the term "" while describing , laying conceptual groundwork for modern hormone research. Solomon Berson collaborated with Yalow on , advancing immunoassay techniques despite his early death. Ongoing research highlights endocrine disruptors like (BPA) and in plastics, which mimic and disrupt function, with studies linking exposure to reproductive and metabolic disorders; the emphasizes reducing plastic use to mitigate these effects.

Professional Aspects

Education and Training Pathways

Aspiring endocrinologists typically begin their educational journey with an , focusing on pre-medical coursework that includes one year each of , , , and physics, often supplemented by biochemistry, , and English. These prerequisites prepare students for the (MCAT), a standardized required for entry into medical school, which assesses knowledge in biological and physical sciences, critical analysis, and reasoning skills. Completion of a , usually in a science-related field like or chemistry, typically takes four years and forms the foundation for advanced medical training. Medical school follows, lasting four years and divided into two phases: the initial two years emphasize basic sciences, including introductory endocrinology topics such as hormone physiology and endocrine system disorders, while the latter two years involve clinical rotations in various specialties, providing early exposure to patient care. Upon earning a Doctor of Medicine (MD) or Doctor of Osteopathic Medicine (DO) degree, graduates must complete a three-year residency in internal medicine, accredited by the Accreditation Council for Graduate Medical Education (ACGME), where they gain broad clinical experience in adult medicine, including rotations that touch on endocrine conditions like diabetes and thyroid disorders. This residency builds the core competencies required for subspecialty training. Subspecialty training occurs through a fellowship in endocrinology, diabetes, and , which requires at least 24 months of ACGME-accredited education following internal medicine residency, including a minimum of 12 months of direct clinical experience in managing hormone-related disorders such as pituitary, adrenal, and reproductive endocrinopathies. During this period, fellows engage in hands-on activities like thyroid ultrasound interpretation, management, and continuous glucose monitoring, under the supervision of certified faculty, to develop expertise in both diagnostic and therapeutic approaches to endocrine diseases. Some programs extend to three years to incorporate additional research or advanced clinical training. Training pathways may vary by country; the above describes the standard route. Certification as an endocrinologist is granted by the American Board of Internal Medicine (ABIM) upon successful completion of the subspecialty examination, which evaluates knowledge in areas like diabetes, thyroid disease, and metabolic disorders; candidates must also hold prior certification in internal medicine and maintain an unrestricted medical license. To sustain certification, endocrinologists participate in ABIM's Maintenance of Certification (MOC) program, involving periodic assessments every five to ten years, including knowledge exams or longitudinal assessments, alongside continuing medical education credits focused on updates in endocrine care. These requirements ensure ongoing professional competence in a rapidly evolving field.

Role and Scope of Endocrinologists

Endocrinologists are physicians who specialize in the , treatment, and of disorders related to the endocrine system, which includes glands that produce regulating , growth, , and stress response. Their scope encompasses evaluating patient histories, ordering and interpreting diagnostic tests such as blood hormone levels and , and developing personalized treatment plans that may involve medications, lifestyle modifications, or referrals. In clinical practice, endocrinologists manage a variety of hormone-related conditions, including overseeing clinics where they adjust insulin therapies and educate patients on glycemic control to prevent complications like neuropathy or . They also conduct follow-up care for patients, monitoring tumor markers and thyroid function post-surgery or radiation to ensure remission and manage . Additionally, in reproductive endocrinology consultations, they address issues such as (PCOS) or by assessing hormonal imbalances and recommending treatments like . Beyond direct patient care, endocrinologists contribute to research and academia by designing and leading clinical trials on hormone replacement therapies, such as investigating novel insulin analogs for to improve long-term outcomes. In academic settings, they teach medical students and about endocrine , often integrating case-based learning to enhance diagnostic skills in complex hormonal disorders. These roles advance evidence-based practices and foster the next generation of specialists. Endocrinologists frequently engage in multidisciplinary to optimize outcomes, working with surgeons to plan transsphenoidal resections for pituitary adenomas and coordinate postoperative hormone replacement. They also partner with nutritionists and dietitians in managing , integrating dietary interventions with pharmacological treatments to address and obesity-related risks. Such team-based approaches, often seen in endocrine tumor boards or programs, ensure comprehensive care for multifaceted conditions. The field includes several subspecialties that allow endocrinologists to focus on specific populations or systems; for instance, pediatric endocrinologists treat children and adolescents with growth disorders, issues, or , tailoring interventions to developmental stages. Endocrinologists with expertise in focus on disorders involving the and pituitary, such as or , often bridging and endocrinology to manage symptoms like hormonal dysregulation from tumors. These areas of focus expand the scope to address age-specific or neurologically intertwined endocrine challenges. Global variations in endocrinology practice reflect differences in healthcare systems and disease burdens; for example, , endocrinologists may handle higher volumes of prescriptions for pediatric compared to , where stricter guidelines limit approvals to severe cases. Building on their specialized training, these professionals adapt their roles to regional needs, such as emphasizing preventive metabolic care in amid rising rates.

References

  1. https://www.sciencedirect.com/topics/medicine-and-dentistry/endocrinology
  2. https://www.endocrinology.org/about-us/what-is-endocrinology/
  3. https://my.clevelandclinic.org/health/articles/22691-endocrinologist
  4. https://pmc.ncbi.nlm.nih.gov/articles/PMC6761896/
  5. https://www.urmc.rochester.edu/childrens-hospital/endocrinology/endocrine-system.aspx
  6. https://opentext.uoregon.edu/animalphysiology/chapter/7-5-endocrine-glands/
  7. https://pubmed.ncbi.nlm.nih.gov/17459911/
  8. https://vivo.colostate.edu/hbooks/pathphys/endocrine/basics/control.html
  9. https://pmc.ncbi.nlm.nih.gov/articles/PMC2647703/
  10. https://www.ncbi.nlm.nih.gov/books/NBK279070/
  11. https://www.ncbi.nlm.nih.gov/books/NBK550972/
  12. https://pmc.ncbi.nlm.nih.gov/articles/PMC4240627/
  13. https://www.ncbi.nlm.nih.gov/books/NBK535380/
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC2064894/
  15. https://www.ncbi.nlm.nih.gov/books/NBK20/
  16. https://www.ncbi.nlm.nih.gov/books/NBK507716/
  17. https://opentextbc.ca/biology/chapter/18-1-types-of-hormones/
  18. https://chem.libretexts.org/Bookshelves/Introductory_Chemistry/Chemistry_for_Changing_Times_%28Hill_and_McCreary%29/18%253A_Drugs/18.05%253A_Hormones_-_The_Regulators
  19. https://www.ncbi.nlm.nih.gov/books/NBK500006/
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC8232639/
  21. https://www.ncbi.nlm.nih.gov/books/NBK482141/
  22. https://histology.oit.duke.edu/MBS/Videos/Phys/Phys%25201.5%2520Endo%2520Gen%2520Concepts/Phys%25201.5%2520Endo%2520Gen%2520Concepts%2520NOTES.pdf
  23. https://www.merckvetmanual.com/endocrine-system/endocrine-system-introduction/general-chemical-structure-and-function-of-the-endocrine-system-of-animals
  24. https://courses.lumenlearning.com/suny-ap2/chapter/hormones/
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC3433956/
  26. https://pmc.ncbi.nlm.nih.gov/articles/PMC5816795/
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC2725002/
  28. https://pubmed.ncbi.nlm.nih.gov/33385475/
  29. https://pubmed.ncbi.nlm.nih.gov/28585154/
  30. https://pmc.ncbi.nlm.nih.gov/articles/PMC8368230/
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC9900367/
  32. https://www.ncbi.nlm.nih.gov/books/NBK279113/
  33. https://pubmed.ncbi.nlm.nih.gov/1548637/
  34. https://radiologykey.com/endocrine-system-2/
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC10045406/
  36. https://pmc.ncbi.nlm.nih.gov/articles/PMC7609334/
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC4952635/
  38. https://pmc.ncbi.nlm.nih.gov/articles/PMC11898309/
  39. https://pubmed.ncbi.nlm.nih.gov/24893135/
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC9386598/
  41. https://www.endocrine.org/clinical-practice-guidelines/primary-aldosteronism-2
  42. https://journals.sagepub.com/doi/10.1089/hum.2022.29215.ada
  43. https://www.healio.com/news/endocrinology/20250414/after-decades-with-only-one-option-new-therapies-emerge-for-congenial-adrenal-hyperplasia
  44. https://www.thyroid.org/patient-thyroid-information/ct-for-patients/august-2022/vol-15-issue-8-p-7-8/
  45. https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/
  46. https://pmc.ncbi.nlm.nih.gov/articles/PMC12312824/
  47. https://pmc.ncbi.nlm.nih.gov/articles/PMC3608918/
  48. https://pmc.ncbi.nlm.nih.gov/articles/PMC12486228/
  49. https://www.ncbi.nlm.nih.gov/books/NBK459262/
  50. https://pmc.ncbi.nlm.nih.gov/articles/PMC10583117/
  51. https://www.ncbi.nlm.nih.gov/books/NBK560723/
  52. https://pmc.ncbi.nlm.nih.gov/articles/PMC80211/
  53. https://pmc.ncbi.nlm.nih.gov/articles/PMC3749019/
  54. https://www.nejm.org/doi/full/10.1056/NEJMra1110560
  55. https://pmc.ncbi.nlm.nih.gov/articles/PMC8939383/
  56. https://hekint.org/2020/02/06/experimental-evidence-for-the-humoral-circulatory-system/
  57. http://labs.bio.unc.edu/Goldstein/Berthold1849.pdf
  58. https://pedsendo.org/historical-tidbits/historic-tidbit-arnold-adolph-berthold-1803-1861-testis-transplantation-and-the-regain-of-male-sexual-characteristics-and-behaviors/
  59. http://labs.bio.unc.edu/Goldstein/Berthold.pdf
  60. https://pmc.ncbi.nlm.nih.gov/articles/PMC11473112/
  61. https://www.jbc.org/article/S0021-9258%2820%2985219-3/fulltext
  62. https://insulin.library.utoronto.ca/
  63. https://pmc.ncbi.nlm.nih.gov/articles/PMC6205949/
  64. https://joe.bioscientifica.com/view/journals/joe/184/1/1840005.xml
  65. https://pmc.ncbi.nlm.nih.gov/articles/PMC1369102/
  66. https://www.endocrine.org/-/media/endocrine/files/advocacy/society-testimony/ursula-kaiser-072221-statement-arpah-listening-session.pdf
  67. https://www.sciencehistory.org/education/scientific-biographies/rosalyn-yalow-and-solomon-berson/
  68. https://civilrights.ku.edu/rosalyn-sussman-yalow-phd
  69. https://www.acs.org/education/whatischemistry/women-scientists/rosalyn-sussman-yalow.html
  70. https://www.gene.com/stories/cloning-insulin
  71. https://www.fda.gov/about-fda/fda-history-exhibits/100-years-insulin
  72. https://americanhistory.si.edu/blog/2012/10/human-growth-hormone.html
  73. https://www.nature.com/articles/372425a0
  74. https://pmc.ncbi.nlm.nih.gov/articles/PMC3413641/
  75. https://pmc.ncbi.nlm.nih.gov/articles/PMC6474072/
  76. https://www.cureus.com/articles/275769-glucagon-like-peptide-1-glp-1-receptor-agonists-exploring-their-impact-on-diabetes-obesity-and-cardiovascular-health-through-a-comprehensive-literature-review
  77. https://www.fda.gov/news-events/press-announcements/fda-approves-new-medications-treatment-type-2-diabetes
  78. https://www.endocrine.org/topics/edc/plastics-edcs-and-health
  79. https://students-residents.aamc.org/medical-school-admission-requirements/required-premedical-coursework-and-competencies
  80. https://www.verywellhealth.com/how-to-become-an-endocrinologist-1736293
  81. https://medschoolinsiders.com/medical-student/so-you-want-to-be-an-endocrinologist/
  82. https://www.acgme.org/globalassets/pfassets/programrequirements/2025-reformatted-requirements/143_endocrinologydiabetesmetabolism_2025_reformatted.pdf
  83. https://www.abim.org/certification/policies/internal-medicine-subspecialty-policies/endocrinology-diabetes-and-metabolism/
  84. https://www.abim.org/maintenance-of-certification/
  85. https://www.endocrine.org/education-and-training/cme-and-moc
  86. https://www.aace.com/all-about-endocrinology/what-endocrinologist
  87. https://www.aace.com/all-about-endocrinology/what-endocrinology
  88. https://www.webmd.com/a-to-z-guides/what-is-an-endocrinologist
  89. https://www.healthdirect.gov.au/endocrinologist
  90. https://www.saba.edu/blog/what-is-an-endocrinologist
  91. https://www.endocrine.org/our-community/career-and-professional-development/endocareers
  92. https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1513893/full
  93. https://www.cdc.gov/diabetes-toolkit/php/staffing-models/multidiscipline-team.html
  94. https://www.topdoctors.co.uk/medical-articles/integrating-multidisciplinary-approaches-in-the-management-of-complex-endocrine-disorders/
  95. https://www.mayoclinic.org/departments-centers/childrens-center/overview/specialty-groups/pediatric-endocrinology/overview
  96. https://paediatric-endocrinology.medwirenews.com/news/growth-hormone-prescription-differences-highlighted-for-usa-vs-europe/
  97. https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.26.6.w678
Add your contribution
Related Hubs
User Avatar
No comments yet.